1. Central and peripheral haemodynamics, circulating blood volume and plasma renin activity (PRA) were investigated under resting conditions in 97 patients with chronic nonuraemic renal parenchymatous disease and without anaemia. For comparison a group of 17 healthy subjects was used.
1. Central and peripheral haemodynamics, circulating blood volume and plasma renin activity (PRA) were investigated under resting conditions in 97 patients with chronic nonuraemic renal parenchymatous disease and without anaemia. For comparison a group of 17 healthy subjects was used.
2. An initial abnormality appeared in 12 out of 32 normotensive renal patients. It consisted of a markedly increased circulating blood volume, raised cardiac output, low total peripheral and forearm vascular resistance, hyperfusion of the forearm and increased venous distensibdity. PRA was slightly (but insignificantly) higher in these hyperkinetic subjects with relaxed peripheral vessels than in the other 20 normotensive renal patients who did not differ haemodynamically from the control subjects.
3. Fifteen out of 47 renal patients with a mild or moderate hypertension (stage 1-11 WHO) were hyperkinetic. However, in these there was no compensatory vasodilatation in response to the high cardiac output: forearm blood flow was normal and venous distensibility below that of the control subjects. Blood volume was normal. Plasma renin activity (PRA) was the same as in the normotensive renal patients.
4.
The difference between stage 1-11 and stage I11 was due entirely to a rise in total peripheral vascular resistance.
5. A re-examination of these patients 2-8 years after they had been first studied revealed that 11 out of the 12 originally hyperkinetic Correspondence: Professor Dr med. J. Brod. Second Chair of Medicine, Department of Nephrology, Medizinische Hochschule Hannover, Postfach 610180, Karl-Wiechert-Allee 9, 3000 Hannover 61, W. Germany. normotensive renal patients were now hypertensive compared with only one-half of the originally normokinetic normotensive renal subjects.
6. It is concluded that an inability of the diseased kidney to control volume homoeostasis leads to hypervolaemia, which raises cardiac output in the renal patients whilst still normotensive. As long as the arterioles adjust to the high output and the capacitance system to the high volume, blood pressure remains normal. When this adaptation of the periphery ceases, blood pressure rises, normalizing (possibly through a pressure diuresis) blood volume. PRA does not correlate with any of these changes and only in advanced renal hypertension may its rise partly contribute to the maintenance of high blood pressure without being its cause.
Introduction
In the original paper on the pathology of the disease which bears his name, Bright t 1 I found that 52 of 100 patients with albuminous urhe at autopsy had a hypertrophied left ventricle: in 22 (correctly 23) of these the hypertrophy could not be attributed to either valvular disease or to disease of the wall of the aorta. He concluded 'either that the altered quality of the blood affords irregular and unwonted stimulus to the organ immediately; or, that it so affects the minute and capillary circulation, as to render greater action necessary to force the blood through the distal subdivisions of the vascular system'. S i y years later this stimulus was defined as high blood pressure. Since then innumerable efforts have J. Brod et aI. been made to find the cause of the rise of blood pressure in chronic renal disease. For many years it seemed possible that the explanation lay in the renin-angiotensin system. The reasons for this were as follows: (1) angiotensin is one of the most powerful physiological vasoconstrictors known [21; (2) it is produced in increased amounts by the ischaemic kidney 131; (3) the blood levels of renin and angiotension were reported to be raised in one in three of a miscellaneous group of renal patients whose residual renal function was not defined (41 and in uraemic subjects [5, 61. However, others [7, 81 could not confirm these findings in non-uraemic hypertensive renal patients. Also experiments in animals with Goldblatt hypertension suggest that renin and angiotensin, although increased in the early phase, then normalize despite the continued elevation of blood pressure 191.
In addition it was uncertain whether hypertension begins with a generalized vasoconstriction, since, in the same animal model, an initial high cardiac output without a raised total peripheral vascular resistance was found [lo, 111. For this reason a detailed investigation was carried out in a large group of patients with renal disease with and without hypertension and a comparison made with healthy subjects. Additionally, we have reinvestigated their clinical condition, blood pressure and renal function 2-8 years after the initial study.
Methods
The original haemodynamic study involved 97 patients with chronic renal parenchymatous disease and 17 healthy normotensive subjects (convalescent from minor illnesses). The renal patients had glomerulonephritis (46), chronic pyelonephritis or analgesic nephropathy (36) and polycystic kidney disease (15). Subjects were considered hypertensive if direct blood pressure measurements made under the conditions of the study repeatedly exceeded 145/95 mmHg or if mean blood pressure was greater than 115 mmHg. These values were used to classify the patients into normotensive and hypertensive groups and agreed with indirect measurements (diastolic pressure, phase 5) made under resting conditions on the ward before and after the haemodynamic study. Patients were either untreated or hypertensive therapy was discontinued 3 weeks before the investigation. All the patients and control subjects were admitted for at least 3 days preceding the haemodynamic study. They received a hospital diet containing 7-10 g of sodium chloride/day : this was verified by measuring the output of sodium chloride in the urine. Hypertension was staged according to WHO criteria (1962) [121, the intensity of proteinuria and reduction of renal function caused by the primary renal disease being disregarded. On the basis of this classification 32 of the renal patients were normotensive, 49 were hypertensive at stages 1-11 (two patients were excluded from the study because of unreliable data on cardiac output) and 16 had hypertension at stage 111. The hypertensive subjects were slightly older than the normotensive ones but the difference was statistically insignificant. It was not possible to match the patients and control subjects for sex and weight but there was no statistically significant difference between the sex distribution and the weights of the individual sub-groups (Table 1) . None of the patients with stage I11 hypertension had clinical signs or symptoms of heart failure.
All the subjects had a detailed clinical examination including an ECG, chest X-ray, examination of the ocular fundi and a complete nephrological examination. This consisted of urine analysis with a quantitative estimation of protein excretion and microelectrophoresis, Addis count, urine bacteriology, endogenous creatinine clearance (two 12 h collection periods), urine concentration test, intravenous pyelography, renal scan and isotope renography, the relevant biochemical measurements in plasma, a blood count and measurement of erythrocyte sedimentation rate.
In all subjects in whom glomerulonephritis was suspected, the diagnosis was confirmed by renal biopsy. All subjects with a haemoglobin concentration below 12.0 g/dl were excluded from the investigation, as also were any patients whose glomerular filtration rate was below 50 ml/min.
The follow-up investigation 2-8 years later consisted of the following: history, physical examination, indirect measurement of resting blood pressure (diastolic pressure, phase 5) in the recumbent position, ECG, measurement of renal function and, in most instances, fundoscopy. During the interval the patients were seen on several occasions when, apart from recording symptoms and signs, indirect blood pressure and endogenous creatinine clearance or plasma creatinine were also measured. As in the previous haemodynamic study, a subject was considered hypertensive if his blood pressure under resting conditions exceeded 145/95 mmHg on several occasions.
The investigation was carried out in the morning in a quiet laboratory, utmost care being taken to keep the subjects as relaxed as possible and unaware of any recording being done by keeping all the measuring instruments out of sight of the patient by means of a screen. The study proper was started at least 30 min after the introduction and application of all the recording devices. Under local anaesthesia catheters were introduced into the femoral artery and into the right atrium or close to it through a cubital vein. The reference point for blood pressure and venous measurements was the level of the right atrium (one-third of the anterio-posterior distance from the sternum). Cardiac output was measured by the indocyanine green dilution technique, the central venous catheter being used for the injection. The dilution curve was recorded by a photoelectric cell and the area was measured directly by a digital computer. At least three successive measurements were carried out with an interval of 5-10 min between them; if the scatter of the individual data exceeded 10% further measurements were made until this precision had been reached. The intra-individual confidence interval (95%) between single readings under these conditions amounts to 8.3% of the mean.
Peripheral venous pressure was also recorded by a strain-gauge manometer in a vein of the left forearm. Forearm blood flow was measured in the right forearm by a mercury-in-rubber plethysmograph with the hand excluded during each recording by an inflated cuff of the wrist.
Repeated measurements in a single individual under resting conditions were within f 11% of the mean (95% confidence interval).
Forearm blood volume was assessed by a combination of forearm plethysmography and a radionuclide technique [ 131: some 30 min after labelling blood with *13indium-labelled transferrin the activity recorded by a collimator over the forearm reflects its blood volume. By trapping blood in the forearm by an inflated cuff around the upper arm the increase in radioactivity can be equated with the increase in forearm volume measured plethysmographically. From these data the volume of blood in the forearm is calculated. This value, when expressed per mmHg venous pressure, is called venous distensibility (compliance). For both the blood volume and venous distensibility of the forearm the 95% confidence intervals lie within 15% of the mean.
From the cardiac output and forearm blood flow the total and forearm vascular resistance (R) were calculated and expressed in dyn s cm-5 according to the formula R = mean blood pressure/flow per s. 1332. To simplify the values obtained for forearm vascular resistance the results were multiplied by Plasma renin activity (PRA) wds estimated by using the Becton Dickinson renin activity radioimmunoassay kit (lzsI). Values obtained in untreated healthy normotensive supine subjects receiving a diet containing between 7 and 10 g of sodium chloridelday never exceeded 1-55 pmol of angiotensin I h-1 ml-I.
Circulating blood volume was measured by the dilution of 113indium-labelled transferrin 10 min after intravenous injection. Each volume measurement was corrected for body weight and body surface area. Thus the same marker was used for the estimation of both forearm and circulating blood volume but these two variables were measured independently. The isotope has been shown not to leave the intravascular compartment for at least 3 h, even in patients with nephrotic syndrome, and values obtained for circulating blood volume, measured by this method, agree with those obtained with W rlabelled erythrocytes 1141. The error involved in repeated measurements in our laboratory is +5%.
For statistical analysis of the differences between the various subgroups a multivariate analysis of variance (using the program MANOVA in the SPSS-package) was used. Informed consent of all patients was obtained.
Results

Initial study
Comparison of haemodynamic data of healthy subjects and renal patients (Fig. I and Table 2 , columns I , 2, 5, 8). The mean cardiac index (CI) of the normotensive and hypertensive (stages 1-11) renal patients exceeded that of the control subjects, whereas that of the renal hypertensive (stage 111) patients was within control range. The difference between renal hypertensive 1-11 patients and control subjects or hypertensive patients (stage 111) was significant. The increased CI was in the first place due to a higher heart rate. Total peripheral vascular resistance was the same in the control subjects and in the normotensive renal patients, but was increased significantly in both hypertensive groups. Forearm vascular resistance was markedly decreased in the normotensive renal patients compared with the control
Cardiac index
Heart rate Blood volume TPR ( I min-l nr2) (beatshin) (ml/kg body WI.) (dyn s cnr5) Forearm IO-' x Forearm Venous blood flow vascular resistance distensibility PRA (ml min-' I00 ml-') (ml I00 ml-l mmHg-I) (ng h-' ml-I) subjects. However, it was identical in the control subjects and in the hypertensive 1-11 renal patients and markedly increased in the hypertensive renal patients (stage 111). The consequence was hyperperfusion of the forearm in both renal normotensive and renal hypertensive 1-11 patients. In renal hypertensive stage I11 patients forearm blood flow was lower than in the control subjects. Venous compliance was the same in the control subjects and in the renal normotensive patients, and was lower in all the renal hypertensive subjects without being statistically different because of the large scatter of the individual data. Total blood volume was higher in the renal patients than in the control subjects. Mean PRA rose from 0.43 f 0.12 pmol h-' ml-I in the control subjects to 0.84 f 0.12 pmol h-I ml-1 in the normotensive renal patients and to 0.82 & 0.13 pmol h-l ml-1 in hypertensive renal patients. Both these values differ significantly from those of the control subjects but not from each other. In hypertensive renal patients (stage 111) the mean of 1.41 f 0.60 pmol h-1 ml-' was still within the normotensive range and not significantly different from values for the other groups.
Distribution of the individual cardiac indices (Fig. 2) . In about one in three of the normotensive and hypertensive renal patients (stage 1-11) cardiac index was above that of the control subjects and of the hypertensive renal (stage 111) patients; when a line was drawn at 3.57 litres min-' m-2, which was the upper limit of the mean + 2 SD of the control group, it was apparent (Fig.   2) Comparison between normokinetic and hyperkinetic renal patients and control subjects (Table  2, columns 1, 3, 4, 6, 7) . (a) Renal normokinetic subjects. The age and sex distribution and the type of renal disease were similar in the normoand hyper-kinetic subgroups ( Table 1) . As the hyperkinetic renal normotensive patients had the same blood pressure as the control subjects, their calculated total peripheral vascular resistance (1063 f 38 dyn s cmb5) must have been significantly below that of the latter (1405 f 51 dyn s cm-5) and of the normokinetic renal normotensive patients, which was slightly above that of the control subjects (1599 & 51 dyn s cm-s). Forearm vascular resistance showed the same trend. The consequence was a markedly higher forearm perfusion in the hyperkinetic renal normotensive, compared with the normokinetic renal normotensive, patients and the control subjects. Also the veins of the hyperkinetic renal normotensive patients appeared slightly relaxed, forearm venous distensibility being higher in this group than in the normokinetic renal normotensive patients and the control subjects. Differences in central venous pressure, although statistically significant, were minute. The circulating blood volume of the hyperkinetic renal normotensive patients (93.4 f 3.6 ml/kg body weight, 3375 ml/m2 body surface area) was markedly above that of the control subjects (73.4 f 4.8 ml/kg body weight, 2833 ml/m2 body surface area) and also of the normokinetic normotensive renal patients. PRA was higher in the hyperkinetic (1 -02 pmol h-' ml-I) than in the normokinetic normotensive renal patients (0.72 pmol h-' m P ) . Glomerular filtration rate (GFR) in these groups was not different but both values (although within the normal range) were lower than in the healthy control subjects.
(b) Hyperkinetic renal hypertensive patients 1-11. These patients had a cardiac index similar to that of the hyperkinetic normotensive renal patients. Hence, the relaxation of the arterial bed, found in the hyperkinetic normotensive renal patients, was absent in the hyperkinetic patients. Total peripheral vascular resistance in the hyperkinetic renal hypertensive patients was statistically at the level of the healthy control subjects and of the normokinetic normotensive renal patients. Only in the normokinetic hypertensive renal patients did total peripheral and forearm vascular resistance show a trend towards higher values (1772 & 61 dyn s cm-5 and lo5 x 34.05 f 3.06 dyn s cm-3. With the absence of vasodilatation in the forearm vessels blood flow was almost at the control level in the hyperkinetic hypertensive renal patients and was reduced when the higher forearm vascular resistance rose in the normokinetic hypertensive renal patients. Venous distensibility was also lower in the hyperkinetic hypertensive renal patients. Total blood volume was the same as in the control subjects and in the normokinetic normotensive and hypertensive renal patients. PRA was similar in the normokinetic normotensive and renal hypertensive subjects, as well as in the hyperkinetic normotensive and hypertensive renal patients (stage 1-11). Mean GFR in the hypertensive renal patients was slightly further reduced compared with that of the normotensive renal patients without any difference between the subgroups.
Direrence between the renal hypertensive Z-ZZ and ZZZ patients (Table 2, column 8) . This was caused almost entirely by a further rise in total peripheral and forearm vascular resistance. Venous distensibility was below and total blood volume above that of the control subjects. PRA rose conspicuously and exceeded in some the upper normotensive range. GFR fell further but was still only mildly to moderately reduced.
FOllOW-Up study
Twenty-nine renal normotensive and 45 renal hypertensive patients were re-investigated 2-8 years after the original haemodynamic study. A summary of these data is presented in Tables 3  and 4 .
Follow-up of the originally renal normotensive patients. Nineteen out of 29 (66%) patients were now hypertensive (Tables 3 and 4) . Eleven of these 19 were originally hyperkinetic and eight were normokinetic. Among the ten patients who remained normotensive only one had been hyperkinetic and of the original 12 hyperkinetic patients all but one eventually became hypertensive (92%). On the other hand only eight out of the re-examined 17 patients who were originally normokinetic later developed hypertension (47%). The difference is statistically highly significant. Thus the fate of the hyperkinetic renal normotensive patients differed from that of the normokinetic renal normotensive patients.
GFR remained unchanged in those ten patients who remained normotensive and did not deteriorate significantly in any individual patient. Furthermore their hearts remained clinically and electrocardiographically healthy. In three some minor changes were seen in the fundal vessels.
Out of the 19 patients who developed hypertension, at least ten had been treated with anti-hypertensive agents. In five of these 19 patients GFR fell progressively to levels below 40 ml/min. We did not succeed in obtaining reports on the optic fundal changes in all the subjects whose disease had been followed outside the Medical School, but in six of the nine patients whose ocular fundi had been studied grade I and I1 changes were detected. Hypertensive ECG changes developed in seven out of 14 patients.
From the means of GFR in Table 4 and also from  Table 3 it follows that a fall in GFR occurred in only 26.4% of the patients who ultimately became hypertensive. In others this function remained either unchanged or rose.
There was no statistical difference in the type of underlying renal disease between patients who ultimately became hypertensive and those who remained normotensive.
Follow-up in the originally hypertensive patients. In the group of 45 originally hypertensive patients who were re-examined (Table 3) only three became spontaneously normotensive without any apparent reason. The rest remained hypertensive irrespective of whether they were previously normo-or hyper-kinetic.
Discussion
The data presented in this study do not support the view that hypertension in chronic renal disease starts with vasoconstriction, a conclusion which is liable to be drawn if studies on all renal hypertensive patients, irrespective of their stage of development, are combined. When, however, the hypertensive group was broken down according to the WHO stages, we found that in one-third of the patients with chronic renal disease and early hypertension cardiac output was elevated and total peripheral vascular resistance was within the normal range. The same was true for forearm vascular resistance. This finding in early renal hypertensive subjects confirms our earlier results [16, 171 and those of Onesti et al. 1181 . A similarly high cardiac output was found in one-third of renal normotensive subjects; these differed from the renal patients with stage 1-11 hypertension in that their vascular periphery had opened up in response to the increased blood flow. These subjects also differed from the control subjects and from the normokinetic normotensive renal patients in that their veins were relaxed and the total blood volume was raised. This is the earliest haemodynamic change which can be detected in a subject with mildly reduced renal function due to a chronic renal disease. This resembles the pattern of high cardiac output, low normal total peripheral vascular resistance and increased blood volume found in experimental renal hypertension [lo, 111.
The following explanations for the hyperkinetic circulation may be put forward.
(1) It could be due to an emotional response to the haemodynamic investigation, although all precautions were taken to prevent this. The haemodynamic pattern of high cardiac output and heart rate, low total peripheral vascular resistance and high forearm blood flow would be compatible with this idea. However, the high venous distensibility contrasts with the lowering observed in acute emotional stress 1191. Also the higher blood volume could not have accumulated during the short laborabory period preceding its measurement.
(2) The same argument refutes sympathetic stimulation as an explanation, since this would have produced a similar haemodynamic response. There is no reason why chronic nonuraemic renal disease should stimulate the sympathetic nervous system. In addition, in an unpublished study we did not find any correlation between increased cardiac output and oxygen consumption.
(3) The slightly higher PRA in renal subjects, although still within the normotensive control range, might have affected the sympathetic outflow through its known action on the central nervous sympathetic centres [201. As before, the haemodynamic pattern speaks against this possibility.
(4) On the other hand, in almost all of the variables studied, the chronic circulatory change underlying hypertension resembles the human circulation during an isotonic expansion of blood volume [2 1-24]. Under these conditions cardiac output rises. In subjects in whom this does not induce a rise in blood pressure, the peripheral arteriolar and venous beds adjust to the increased volume [251. There are, however, others in whom the capacity and compliance of the vascular bed do not increase and, in these, blood pressure rises.
This dual type of response corresponds exactly to what we found in the course of development of renal hypertension in man. The earliest change in subjects whilst still normotensive was a rise in blood volume and in cardiac output. This could be due to an inability of the kidney to eliminate surplus salt and water, as postulated by Guyton 1261. It is improbable that the slight reduction in GFR, though still within the normal range, is the cause of this. Also, as pointed out in the follow-up section of the Results, and documented in Table  4 , blood pressure was raised in many patients whose GFR was still normal. On the other hand, GFR fell only in those renal patients who developed hypertension, which may have contributed to the downhill course of the disease.
It may be questioned whether the use of endogenous creatinine clearance overestimated the true level of GFR. However, values obtained agreed well with those for inulin clearance which we carried out in several of the patients, and in our 30 years' experience such overestimation, as a rule, does not take place with clearance values above 80 ml/min.
Thus the defect in renal volume homoeostasis probably has an important tubular component. One may speculate whether the somewhat higher PRA, which in itself would not raise blood pressure, may indicate a spill-over of renin released from the juxtaglomerular cells in increased amounts, which might interfere with renal sodium excretion in situ [27,281.
The mechanism by which hypervolaemia might lead to a relaxation of vessels remains to be elucidated. It may be partly reflex [291, but it may also be due to a release of vasoactive substances, e.g. prostacyclin and bradykinin 1301. Blood pressure rises when this adjustment fails. Thus the initial rise in blood pressure in subjects with renal disease is unassociated with any signs of vasoconstriction, total peripheral and forearm vascular resistances being at normotensive control levels.
Because of the large scatter of the individual data for PRA, we found no statistically significant differences between the control subjects and the individual subgroups. Moreover, mean PRA was higher in the hyperkinetic (vasodilated) normotensive renal patients than in the normokinetic (non-vasodilated) one. The same was true for the renal patients with stage 1-11 hypertension. In the latter a prolonged infusion of the angiotensin receptor blocker saralasin did not produce any change in blood pressure or in any other haemodynamic variable [3 11. Only in some of renal patients with stage I11 hypertension did PRA exceed the normotensive range and in one such subject saralasin slightly reduced the blood pressure without normalizing it. Thus, angiotensin does not appear to be the agent primarily responsible for the loss of vascular adjustability in renal patients. Whether this loss is due merely to an overactive Bayliss' mechanism, leading to a thickening of the vascular wall in the manner postulated by Folkow 1321 or whether some other humoral factors play a role remains open.
Thus, we would complement the volume regulatory haemodynamic system of Guyton in the following way (Fig. 3) . When the extracellular fluid and the blood volume increase, the mean systemic pressure (as defined by Guyton) rises and increases cardiac output. If the peripheral vessels adjust to this, blood pressure does not change and no pressure diuresis follows.
The other feedback loop consists of dilution of plasma proteins and a fall in blood viscosity and the mobilization of the still hypothetical natriuretic factor@) which is supposed to block the renal tubular sodium pump. If de Wardener's [331 views are correct, this substance would act not only on the renal tubular cell, but also on the sodium pump in the erythrocyte (341 and in the vascular wall [351, explaining their higher sodium and calcium content. The compliance of the vascular wall during isotonic expansion would be reduced, blood pressure would rise and lead to a pressure diuresis.
Our data indicate that, in renal disease, the circulatory changes are already apparent at a time when the blood pressure is still normal. Moreover, it is those subjects with a hyperkinetic circulation who almost invariably develop hypertension. When this happens, the pressure diuresis probably normalizes the blood volume, explaining why past studies, concentrating on hypertensive renal patients, failed to find an increased circulating blood volume [361. Venous tone increases, allowing the capacitance system to adjust to lower circulating blood volume so that for a time the hyperkinetic circulation persists. However, the hyperfusion of tissues with the continuously repeated and over-taxed Bayliss effect may produce structural changes in the vascular wall, thereby raising total peripheral vascular resistance [321. At a later stage the renin-angiotensin system may contribute to this. However, the latter cannot be the only cause, as explained above.
Thus the data in the present paper support the hypothesis that renal hypertension develops after a hyperkinetic stage in subjects whilst still normotensive. We may therefore conclude that in man a disturbance of renal volume homoeostasis is, as in animal experiments, the primary cause of the rise of blood pressure in chronic parenchymatous renal disease, and it is possible that this may be a common basis for all types of human hypertension. 
